Market Overview

STAAR Surgical and Shinjuku LASIK Clinic in Japan Announce Strategic Cooperation Agreement

Share:

STAAR Surgical Company (NASDAQ:STAA), a leading developer, manufacturer
and marketer of implantable lenses and companion delivery systems for
the eye, and Dr. Maro Kariya of Shinjuku
LASIK Clinic
in Tokyo, today announced they have entered into a
multi-year Strategic Cooperation Agreement to provide STAAR's EVO Visian
ICL™ intraocular lenses as a primary and premium option for patients
seeking visual freedom from spectacles and contact lenses through
refractive eye treatment.

"I am very proud that my clinic has now joined with STAAR Surgical
Company as an official strategic partner to provide STAAR's ICL as a
primary and premium option for patients wanting to experience high
quality vision," stated Dr. Maro Kariya, General Manager of Shinjuku
LASIK Clinic. "Our clinic already has several certified ICL surgeons on
staff and we look forward to growing and working even more closely with
STAAR to achieve our shared goal of providing excellent visual results
to patients," concluded Dr. Kariya.

Caren Mason, President & CEO of STAAR, stated, "Shinjuku LASIK Clinic is
a leading provider of refractive surgery in Japan and has demonstrated
its commitment to STAAR's EVO Visian ICL family of lenses by
significantly increasing their use of the ICL in recent months. The
clinic positions the ICL as a premium option for patients including
those with lower-diopter refractive error. Staff members who have
had ICL surgery are very happy with their visual freedom results and
have positioned the ICL on their website as the primary procedure. This
strategic cooperation agreement with Shinjuku LASIK Clinic expands our
relationship with growth commitments by the clinic and co-marketing
support and certified surgeon and staff training by STAAR."

About STAAR Surgical

STAAR, which has been dedicated solely to ophthalmic surgery for over 30
years, designs, develops, manufactures and markets implantable lenses
for the eye with companion delivery systems. These lenses are intended
to provide visual freedom for patients, lessening or eliminating the
reliance on glasses or contact lenses. All of these lenses are foldable,
which permits the surgeon to insert them through a small incision.
STAAR's lens used in refractive surgery is called an Implantable
Collamer® Lens or "ICL," which includes the EVO Visian ICL™ product
line. More than 800,000 Visian ICLs have been implanted to date. To
learn more about the ICL go to: www.discovericl.com.
STAAR has approximately 400 full-time equivalent employees and markets
lenses in over 75 countries. Headquartered in Monrovia, CA, the company
operates manufacturing facilities in Aliso Viejo, CA and Monrovia, CA.
For more information, please visit the Company's website at www.staar.com.

View Comments and Join the Discussion!